Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
3.450
+0.150 (4.60%)
Dec 3, 2024, 9:54 AM EST - Market open
Daré Bioscience Revenue
Daré Bioscience had revenue of $41.69K in the quarter ending September 30, 2024, a decrease of -95.83%. This brings the company's revenue in the last twelve months to $1.88M, up 88.13% year-over-year. In the year 2023, Daré Bioscience had annual revenue of $2.81M, down -71.92%.
Revenue (ttm)
$1.88M
Revenue Growth
+88.13%
P/S Ratio
14.59
Revenue / Employee
$72,358
Employees
26
Market Cap
30.02M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neuronetics | 72.71M |
HOOKIPA Pharma | 50.00M |
IRIDEX | 48.43M |
Allurion Technologies | 34.75M |
Co-Diagnostics | 7.32M |
Longeveron | 1.85M |
IGC Pharma | 1.18M |
DARE News
- 18 days ago - Daré Bioscience, Inc. (DARE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 26 days ago - Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024 - GlobeNewsWire
- 5 weeks ago - Daré Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health - GlobeNewsWire
- 6 weeks ago - Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC - GlobeNewsWire
- 4 months ago - Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 4 months ago - Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule - GlobeNewsWire